HHS’ Biomedical Advanced Research and Development Authority will provide additional funds to its ongoing partnership with San Diego-based Cue Health, a healthcare technology company, to develop an omicron-genotyping COVID-19 test.
Copyright © 2024 | WordPress Theme by MH Themes